What is HER2?

T Cooke1

  • 1University Department of Surgery, Royal Infirmary, Queen Elizabeth Building, Alexandra Parade, Glasgow G31 2ER, UK.

Insights

Mutations in growth factor receptors, like human epidermal growth factor receptor 2 (HER2), drive cancer. HER2 amplification in breast cancer correlates with poor prognosis, making HER2 status crucial for patient management.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer development is linked to mutations in cell growth-regulating systems, particularly growth factor receptors.
  • The human epidermal growth factor receptor (HER) family plays a key role in normal growth regulation and is well-studied in breast cancer.
  • HER2 is a central member of the HER family, crucial for potentiating intracellular signaling pathways.

Purpose of the Study:

  • To investigate the role of HER2 gene amplification and receptor overexpression in oncogenesis.
  • To highlight the significance of HER2 in breast cancer progression and patient prognosis.
  • To emphasize the clinical importance of determining HER2 status in breast cancer management.

Main Methods:

  • Review of existing research on growth factor receptors and oncogenesis.
  • Analysis of studies linking HER2 gene amplification/receptor overexpression to cancer development.
  • Examination of the association between HER2 status and patient outcomes in breast cancer.

Main Results:

  • Mutations affecting growth factor receptors are implicated in cancer initiation (oncogenesis).
  • HER2 gene amplification/receptor overexpression is observed in a substantial percentage of various tumor types.
  • HER2 amplification/overexpression occurs early in cancer progression and is linked to poorer prognosis in breast cancer patients.

Conclusions:

  • HER2 gene amplification/receptor overexpression is a significant factor in the development and progression of various cancers, notably breast cancer.
  • Determining the HER2 status of breast cancer patients is essential for informed clinical decision-making and treatment planning.
  • Further research into HER2 function and regulation is warranted given its pivotal role in cancer.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...